Frequently Asked Questions

Pouya-Heart is an intelligent phonocardiography machine developed by CAPIS for precise screening of congenital heart diseases (CHD) in children and critical congenital heart diseases (CCHD) in neonates. It uses advanced AI algorithms to analyze heart sounds and detect potential cardiac abnormalities.

Pouya-Heart uses specialized sensors to capture heart sounds (phonocardiography), then analyzes these sounds using patented artificial intelligence algorithms. The system identifies patterns that may indicate congenital heart diseases, providing healthcare professionals with actionable screening results.

Yes, Pouya-Heart is specifically designed for screening critical congenital heart diseases (CCHD) in neonates. It is a non-invasive, passive monitoring technology that requires no active patient participation, making it ideal for newborn screening programs.

CHD (Congenital Heart Disease) refers to any structural heart defect present at birth. CCHD (Critical Congenital Heart Disease) refers to severe heart defects that require intervention within the first year of life. Pouya-Heart is designed to screen for both CHD in children and CCHD in neonates.

No, Pouya-Heart is a screening device, not a diagnostic tool. It helps identify children and neonates who may be at risk of congenital heart diseases and should be referred for further diagnostic evaluation by a cardiologist. The final diagnosis must be made by qualified medical professionals using comprehensive diagnostic procedures.

Pouya-Heart uses clinically proven AI algorithms trained on extensive datasets of heart sounds. While specific accuracy metrics depend on the clinical setting and patient population, the technology has been validated through clinical studies to provide reliable screening results with high sensitivity and specificity.

Pouya-Heart is designed to be used by healthcare professionals including pediatricians, neonatologists, nurses, and trained medical staff. The system is user-friendly and does not require extensive specialized training in cardiology, though proper training in device operation is recommended.

Pouya-Heart can be used in various healthcare settings including hospitals, neonatal intensive care units (NICUs), pediatric clinics, maternity wards, community health centers, and routine health checkup programs.

Yes, the technology behind Pouya-Heart is internationally patented, representing innovative advances in phonocardiography and AI-based cardiac screening.

A typical Pouya-Heart screening is quick and efficient, usually taking only a few minutes. The passive, non-invasive nature of the technology means minimal disruption to the patient and workflow.

CAPIS is based in Mons, Belgium. For inquiries, you can contact us at Info@capis.be.

To learn more about acquiring Pouya-Heart for your healthcare facility, please visit our contact page or email us at Info@capis.be. Our team will be happy to discuss your needs and provide detailed information.